Therefore, our findings enrich the understanding of ANKRD17’s role in HCC-related metastasis, suggesting it as a new therapeutic target for curtailing HCC-induced metastasis and disease recurrence. Here, ANKRD17 is linked to hepatocellular carcinoma.